KENYA'S VACCINE RACE: CAN BIOVAX DELIVER BEFORE THE 2027 DEADLINE?
As Kenya targets its first locally made vaccine trial batch by end-2027, budget data shows major funding for BioVax — but a gap between current and earlier completion targets raises questions about whether the facility can meet its deadline.